메뉴 건너뛰기




Volumn 32, Issue 1, 2015, Pages 10-30

Early Direct and Indirect Impact of Quadrivalent HPV (4HPV) Vaccine on Genital Warts: a Systematic Review

Author keywords

4HPV vaccine; Gardasil; Genital warts; Human papillomavirus; Quadrivalent human papillomavirus vaccine; Vaccine effectiveness; Vaccine impact

Indexed keywords

WART VIRUS VACCINE;

EID: 84925484657     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-015-0178-4     Document Type: Review
Times cited : (52)

References (60)
  • 1
    • 49449093566 scopus 로고    scopus 로고
    • Human papillomavirus genotype distribution in external acuminata condylomata: a large French national study (EDiTH IV)
    • PID: 18637758
    • Aubin F, Pretet JL, Jacquard AC, et al. Human papillomavirus genotype distribution in external acuminata condylomata: a large French national study (EDiTH IV). Clin Infect Dis. 2008;47(5):610–5.
    • (2008) Clin Infect Dis , vol.47 , Issue.5 , pp. 610-615
    • Aubin, F.1    Pretet, J.L.2    Jacquard, A.C.3
  • 2
    • 84925473528 scopus 로고    scopus 로고
    • Centres for Disease Control and Prevention. Genital HPV infection—fact sheet:. Accessed Feb 3, 2013
    • Centres for Disease Control and Prevention. Genital HPV infection—fact sheet: http://www.cdc.gov/std/hpv/stdfact-hpv.htm. Accessed Feb 3, 2013.
  • 3
    • 65649141194 scopus 로고    scopus 로고
    • Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine
    • PID: 19199546
    • Garland SM, Steben M, Sings HL, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis. 2009;199(6):805–14.
    • (2009) J Infect Dis , vol.199 , Issue.6 , pp. 805-814
    • Garland, S.M.1    Steben, M.2    Sings, H.L.3
  • 4
    • 84872797670 scopus 로고    scopus 로고
    • Systematic review of the incidence and prevalence of genital warts
    • PID: 23347441
    • Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis. 2013;13:39.
    • (2013) BMC Infect Dis , vol.13 , pp. 39
    • Patel, H.1    Wagner, M.2    Singhal, P.3    Kothari, S.4
  • 5
    • 0037108603 scopus 로고    scopus 로고
    • External genital warts: diagnosis, treatment, and prevention
    • COI: 1:STN:280:DC%2BD38vptVKnsA%3D%3D, PID: 12353208
    • Wiley DJ, Douglas J, Beutner K, et al. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis. 2002;35(Suppl 2):S210–24.
    • (2002) Clin Infect Dis , vol.35 , pp. 210-224
    • Wiley, D.J.1    Douglas, J.2    Beutner, K.3
  • 6
    • 84887300525 scopus 로고    scopus 로고
    • Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: results of an observational, health-related quality of life study in the UK
    • PID: 24215264
    • Dominiak-Felden G, Cohet C, Atrux-Tallau S, Gilet H, Tristram A, Fiander A. Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: results of an observational, health-related quality of life study in the UK. BMC Public Health. 2013;13(1):1065.
    • (2013) BMC Public Health , vol.13 , Issue.1 , pp. 1065
    • Dominiak-Felden, G.1    Cohet, C.2    Atrux-Tallau, S.3    Gilet, H.4    Tristram, A.5    Fiander, A.6
  • 8
    • 84860901456 scopus 로고    scopus 로고
    • The cost of managing genital warts in the UK
    • COI: 1:STN:280:DC%2BC38nislyqsw%3D%3D, PID: 22581873
    • Lanitis T, Carroll S, O’Mahony C, et al. The cost of managing genital warts in the UK. Int J STD AIDS. 2012;23(3):189–94.
    • (2012) Int J STD AIDS , vol.23 , Issue.3 , pp. 189-194
    • Lanitis, T.1    Carroll, S.2    O’Mahony, C.3
  • 9
    • 84884937597 scopus 로고    scopus 로고
    • Hospitalization for diseases attributable to human papillomavirus in the Veneto Region (North-East Italy)
    • PID: 24094080
    • Baldo V, Cocchio S, Buja A, et al. Hospitalization for diseases attributable to human papillomavirus in the Veneto Region (North-East Italy). BMC Infect Dis. 2013;13:462.
    • (2013) BMC Infect Dis , vol.13 , pp. 462
    • Baldo, V.1    Cocchio, S.2    Buja, A.3
  • 10
    • 84869853111 scopus 로고    scopus 로고
    • Economic burden of human papillomavirus-related diseases in Italy
    • COI: 1:CAS:528:DC%2BC38XhvVags7%2FK, PID: 23185412
    • Baio G, Capone A, Marcellusi A, Mennini FS, Favato G. Economic burden of human papillomavirus-related diseases in Italy. PLoS One. 2012;7(11):e49699.
    • (2012) PLoS One , vol.7 , Issue.11 , pp. 49699
    • Baio, G.1    Capone, A.2    Marcellusi, A.3    Mennini, F.S.4    Favato, G.5
  • 11
    • 84925473527 scopus 로고    scopus 로고
    • European Medicines Agency. European public assessment report (EPAR) for Gardasil:. Accessed Oct 16, 2014
    • European Medicines Agency. European public assessment report (EPAR) for Gardasil: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000703/human_med_000805.jsp&mid=WC0b01ac058001d125&murl=menus/medicines/medicines.jsp&jsenabled=true. Accessed Oct 16, 2014.
  • 12
    • 84876251944 scopus 로고    scopus 로고
    • Human papillomavirus vaccine introduction—the first five years
    • PID: 23199957
    • Markowitz LE, Tsu V, Deeks SL, et al. Human papillomavirus vaccine introduction—the first five years. Vaccine. 2012;30(Suppl 5):F139–48.
    • (2012) Vaccine , vol.30 , pp. 139-148
    • Markowitz, L.E.1    Tsu, V.2    Deeks, S.L.3
  • 13
    • 77749279739 scopus 로고    scopus 로고
    • Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women
    • COI: 1:CAS:528:DC%2BC3cXivFGnuro%3D, PID: 20139221
    • Munoz N, Kjaer SK, Sigurdsson K, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst. 2010;102(5):325–39.
    • (2010) J Natl Cancer Inst , vol.102 , Issue.5 , pp. 325-339
    • Munoz, N.1    Kjaer, S.K.2    Sigurdsson, K.3
  • 14
    • 45249112545 scopus 로고    scopus 로고
    • The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK
    • COI: 1:STN:280:DC%2BD1cvntVyntw%3D%3D, PID: 18503574
    • Dasbach EJ, Insinga RP, Elbasha EH. The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK. BJOG. 2008;115(8):947–56.
    • (2008) BJOG , vol.115 , Issue.8 , pp. 947-956
    • Dasbach, E.J.1    Insinga, R.P.2    Elbasha, E.H.3
  • 15
    • 33846102585 scopus 로고    scopus 로고
    • Model for assessing human papillomavirus vaccination strategies
    • PID: 17370513
    • Elbasha EH, Dasbach EJ, Insinga RP. Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis. 2007;13(1):28–41.
    • (2007) Emerg Infect Dis , vol.13 , Issue.1 , pp. 28-41
    • Elbasha, E.H.1    Dasbach, E.J.2    Insinga, R.P.3
  • 16
    • 84890830358 scopus 로고    scopus 로고
    • A new surveillance gynecological network to assess the incidence and prevalence of genital warts in the Italian female population: lessons learned
    • COI: 1:STN:280:DC%2BC2c%2FmtFWnug%3D%3D, PID: 24096294
    • Suligoi B, Salfa MC, Mariani L, et al. A new surveillance gynecological network to assess the incidence and prevalence of genital warts in the Italian female population: lessons learned. Minerva Ginecol. 2013;65(5):577–85.
    • (2013) Minerva Ginecol , vol.65 , Issue.5 , pp. 577-585
    • Suligoi, B.1    Salfa, M.C.2    Mariani, L.3
  • 17
    • 44949191262 scopus 로고    scopus 로고
    • A new approach to estimate genital warts incidence and prevalence in the Italian general female population
    • Vittori G, Matteelli A, Boselli F, Naldi L, Emberti Gialloreti L. A new approach to estimate genital warts incidence and prevalence in the Italian general female population. Ital J Gynaecol Obstet. 2008;20(1):33–4.
    • (2008) Ital J Gynaecol Obstet , vol.20 , Issue.1 , pp. 33-34
    • Vittori, G.1    Matteelli, A.2    Boselli, F.3    Naldi, L.4    Emberti Gialloreti, L.5
  • 18
    • 84877739847 scopus 로고    scopus 로고
    • Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data
    • PID: 23599298
    • Ali H, Donovan B, Wand H, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ. 2013;346:f2032.
    • (2013) BMJ , vol.346 , pp. 2032
    • Ali, H.1    Donovan, B.2    Wand, H.3
  • 19
    • 78650255358 scopus 로고    scopus 로고
    • Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
    • PID: 21067976
    • Donovan B, Franklin N, Guy R, et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis. 2011;11(1):39–44.
    • (2011) Lancet Infect Dis , vol.11 , Issue.1 , pp. 39-44
    • Donovan, B.1    Franklin, N.2    Guy, R.3
  • 20
    • 72449210177 scopus 로고    scopus 로고
    • Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women
    • COI: 1:STN:280:DC%2BD1MjotVGrtg%3D%3D, PID: 19837728
    • Fairley CK, Hocking JS, Gurrin LC, Chen MY, Donovan B, Bradshaw CS. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect. 2009;85(7):499–502.
    • (2009) Sex Transm Infect , vol.85 , Issue.7 , pp. 499-502
    • Fairley, C.K.1    Hocking, J.S.2    Gurrin, L.C.3    Chen, M.Y.4    Donovan, B.5    Bradshaw, C.S.6
  • 21
    • 82555169731 scopus 로고    scopus 로고
    • The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme
    • PID: 21970896
    • Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect. 2011;87(7):544–7.
    • (2011) Sex Transm Infect , vol.87 , Issue.7 , pp. 544-547
    • Read, T.R.1    Hocking, J.S.2    Chen, M.Y.3    Donovan, B.4    Bradshaw, C.S.5    Fairley, C.K.6
  • 22
    • 84922429116 scopus 로고    scopus 로고
    • Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data
    • PID: 25117753
    • Smith MA, Liu B, McIntyre P, Menzies R, Dey A, Canfell K. Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data. J Infect Dis. 2015;211(1):91–9.
    • (2015) J Infect Dis , vol.211 , Issue.1 , pp. 91-99
    • Smith, M.A.1    Liu, B.2    McIntyre, P.3    Menzies, R.4    Dey, A.5    Canfell, K.6
  • 23
    • 84911395455 scopus 로고    scopus 로고
    • Genital warts and chlamydia in Australian women: comparison of national population-based surveys in 2001 and 2011
    • PID: 24570485
    • Liu B, Donovan B, Brotherton JM, Saville M, Kaldor JM. Genital warts and chlamydia in Australian women: comparison of national population-based surveys in 2001 and 2011. Sex Transm Infect. 2014;90(7):532–7.
    • (2014) Sex Transm Infect , vol.90 , Issue.7 , pp. 532-537
    • Liu, B.1    Donovan, B.2    Brotherton, J.M.3    Saville, M.4    Kaldor, J.M.5
  • 24
    • 79961040927 scopus 로고    scopus 로고
    • Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services
    • PID: 21952330
    • Oliphant J, Perkins N. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services. N Z Med J. 2011;124(1339):51–8.
    • (2011) N Z Med J , vol.124 , Issue.1339 , pp. 51-58
    • Oliphant, J.1    Perkins, N.2
  • 25
    • 84895537178 scopus 로고    scopus 로고
    • Evidence for effectiveness of a national HPV vaccination programme: national prescription data from New Zealand
    • PID: 24526666
    • Wilson N, Morgan J, Baker MG. Evidence for effectiveness of a national HPV vaccination programme: national prescription data from New Zealand. Sex Transm Infect. 2014;90(2):103.
    • (2014) Sex Transm Infect , vol.90 , Issue.2 , pp. 103
    • Wilson, N.1    Morgan, J.2    Baker, M.G.3
  • 26
    • 84861947648 scopus 로고    scopus 로고
    • Evidence of human papillomavirus vaccine-effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007–2010
    • PID: 22420808
    • Bauer HM, Wright G, Chow J. Evidence of human papillomavirus vaccine-effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007–2010. Am J Public Health. 2012;102(5):833–5.
    • (2012) Am J Public Health , vol.102 , Issue.5 , pp. 833-835
    • Bauer, H.M.1    Wright, G.2    Chow, J.3
  • 27
    • 84880145384 scopus 로고    scopus 로고
    • Prevalence of anogenital warts among participants in private health plans in the United States, 2003–2010: potential impact of human papillomavirus vaccination
    • PID: 23763409
    • Flagg EW, Schwartz R, Weinstock H. Prevalence of anogenital warts among participants in private health plans in the United States, 2003–2010: potential impact of human papillomavirus vaccination. Am J Public Health. 2013;103(8):1428–35.
    • (2013) Am J Public Health , vol.103 , Issue.8 , pp. 1428-1435
    • Flagg, E.W.1    Schwartz, R.2    Weinstock, H.3
  • 28
    • 84883877385 scopus 로고    scopus 로고
    • Incidence of genital warts among U.S. service members before and after the introduction of the quadrivalent human papillomavirus vaccine
    • PID: 23461306
    • Nsouli-Maktabi H, Ludwig SL, Yerubandi UD, Gaydos JC. Incidence of genital warts among U.S. service members before and after the introduction of the quadrivalent human papillomavirus vaccine. MSMR. 2013;20(2):17–20.
    • (2013) MSMR , vol.20 , Issue.2 , pp. 17-20
    • Nsouli-Maktabi, H.1    Ludwig, S.L.2    Yerubandi, U.D.3    Gaydos, J.C.4
  • 29
    • 84872955162 scopus 로고    scopus 로고
    • Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program
    • PID: 23324976
    • Baandrup L, Blomberg M, Dehlendorff C, Sand C, Andersen KK, Kjaer SK. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program. Sex Transm Dis. 2013;40(2):130–5.
    • (2013) Sex Transm Dis , vol.40 , Issue.2 , pp. 130-135
    • Baandrup, L.1    Blomberg, M.2    Dehlendorff, C.3    Sand, C.4    Andersen, K.K.5    Kjaer, S.K.6
  • 30
    • 84884406591 scopus 로고    scopus 로고
    • Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark
    • PID: 23804192
    • Blomberg M, Dehlendorff C, Munk C, Kjaer SK. Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark. Clin Infect Dis. 2013;57(7):929–34.
    • (2013) Clin Infect Dis , vol.57 , Issue.7 , pp. 929-934
    • Blomberg, M.1    Dehlendorff, C.2    Munk, C.3    Kjaer, S.K.4
  • 31
    • 84871539712 scopus 로고    scopus 로고
    • Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany—an ecologic study
    • PID: 23250300
    • Mikolajczyk RT, Kraut AA, Horn J, Schulze-Rath R, Garbe E. Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany—an ecologic study. Sex Transm Dis. 2013;40(1):28–31.
    • (2013) Sex Transm Dis , vol.40 , Issue.1 , pp. 28-31
    • Mikolajczyk, R.T.1    Kraut, A.A.2    Horn, J.3    Schulze-Rath, R.4    Garbe, E.5
  • 32
    • 84865711912 scopus 로고    scopus 로고
    • Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability
    • PID: 22815381
    • Leval A, Herweijer E, Arnheim-Dahlstrom L, et al. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis. 2012;206(6):860–6.
    • (2012) J Infect Dis , vol.206 , Issue.6 , pp. 860-866
    • Leval, A.1    Herweijer, E.2    Arnheim-Dahlstrom, L.3
  • 33
    • 84876008961 scopus 로고    scopus 로고
    • Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study
    • COI: 1:CAS:528:DC%2BC3sXlsV2rs7w%3D, PID: 23486550
    • Leval A, Herweijer E, Ploner A, et al. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. J Natl Cancer Inst. 2013;105(7):469–74.
    • (2013) J Natl Cancer Inst , vol.105 , Issue.7 , pp. 469-474
    • Leval, A.1    Herweijer, E.2    Ploner, A.3
  • 34
    • 80053445038 scopus 로고    scopus 로고
    • Adolescent and young adult HPV vaccination in Australia: achievements and challenges
    • PID: 21962468
    • Garland SM, Skinner SR, Brotherton JM. Adolescent and young adult HPV vaccination in Australia: achievements and challenges. Prev Med. 2011;53(Suppl 1):S29–35.
    • (2011) Prev Med , vol.53 , pp. 29-35
    • Garland, S.M.1    Skinner, S.R.2    Brotherton, J.M.3
  • 35
    • 84255198571 scopus 로고    scopus 로고
    • Recommendations on the use of quadrivalent human papillomavirus vaccination in males—Advisory Committee on Immunization Practices (ACIP) 2011
    • Centres for Disease Control and Prevention. Recommendations on the use of quadrivalent human papillomavirus vaccination in males—Advisory Committee on Immunization Practices (ACIP) 2011. MMWR. 2011;60(50):1705–8.
    • (2011) MMWR , vol.60 , Issue.50 , pp. 1705-1708
    • Centres for Disease Control and Prevention1
  • 36
    • 33947595236 scopus 로고    scopus 로고
    • Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • PID: 17380109
    • Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson HW, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2007;56(RR-2):1–24.
    • (2007) MMWR , vol.56 , Issue.RR-2 , pp. 1-24
    • Markowitz, L.E.1    Dunne, E.F.2    Saraiya, M.3    Lawson, H.W.4    Chesson, H.W.5    Unger, E.R.6
  • 37
    • 80052179732 scopus 로고    scopus 로고
    • National and state vaccination coverage among adolescents aged 13 through 17 years—United States, 2010
    • Dorell C, Stokley S, Yankey D, Liang JL, Markowitz LE. National and state vaccination coverage among adolescents aged 13 through 17 years—United States, 2010. MMWR. 2011;60(33):1117–23.
    • (2011) MMWR. , vol.60 , Issue.33 , pp. 1117-1123
    • Dorell, C.1    Stokley, S.2    Yankey, D.3    Liang, J.L.4    Markowitz, L.E.5
  • 39
    • 84907450493 scopus 로고    scopus 로고
    • Decreased management of genital warts in young women in Australian general practice post introduction of national HPV vaccination program: results from a nationally representative cross-sectional general practice study
    • PID: 25180698
    • Harrison C, Britt H, Garland S, et al. Decreased management of genital warts in young women in Australian general practice post introduction of national HPV vaccination program: results from a nationally representative cross-sectional general practice study. PLoS One. 2014;9(9):e105967.
    • (2014) PLoS One , vol.9 , Issue.9 , pp. 105967
    • Harrison, C.1    Britt, H.2    Garland, S.3
  • 40
    • 84925473526 scopus 로고    scopus 로고
    • Australian Government Department of Health. Gardasil (quadrivalent human papillomavirus vaccine):. Accessed Feb 3, 2013
    • Australian Government Department of Health. Gardasil (quadrivalent human papillomavirus vaccine): http://www.tga.gov.au/safety/alerts-medicine-gardasil-130516.htm#.Uu-Qjfl5OSo. Accessed Feb 3, 2013.
  • 41
    • 84875271814 scopus 로고    scopus 로고
    • Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases
    • PID: 23199951
    • Bosch FX, Tsu V, Vorsters A, Van Damme P, Kane MA. Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases. Vaccine. 2012;30(Suppl 5):F1–11.
    • (2012) Vaccine , vol.30 , pp. 1-11
    • Bosch, F.X.1    Tsu, V.2    Vorsters, A.3    Van Damme, P.4    Kane, M.A.5
  • 42
    • 84875890775 scopus 로고    scopus 로고
    • Australia launches national scheme to vaccinate boys against HPV
    • PID: 23404164
    • Brill D. Australia launches national scheme to vaccinate boys against HPV. BMJ. 2013;346:f924.
    • (2013) BMJ , vol.346 , pp. 924
    • Brill, D.1
  • 43
    • 84925473525 scopus 로고    scopus 로고
    • Austrian Federal Ministry of Health. Accessed Dec 3, 2014
    • Austrian Federal Ministry of Health. http://www.bmg.gv.at/home/Startseite/aktuelle_Meldungen/HPV_Impfung_gratis. Accessed Dec 3, 2014.
  • 44
    • 84925473524 scopus 로고    scopus 로고
    • Austrian Vaccination Schedule 2014:. Accessed Dec 3, 2014
    • Austrian Vaccination Schedule 2014: http://bmg.gv.at/cms/home/attachments/8/9/4/CH1100/CMS1389365860013/impfplan2014.pdf. Accessed Dec 3, 2014.
  • 45
    • 84907450638 scopus 로고    scopus 로고
    • Time to vaccinate boys against HPV infection and cancer, say parliamentarians with special interest in public health
    • PID: 25249311
    • Baron J, Beresford P, Gould J, Patel K, Nash P, Freer M. Time to vaccinate boys against HPV infection and cancer, say parliamentarians with special interest in public health. BMJ. 2014;349:g5789.
    • (2014) BMJ , vol.349 , pp. 5789
    • Baron, J.1    Beresford, P.2    Gould, J.3    Patel, K.4    Nash, P.5    Freer, M.6
  • 46
    • 84885393034 scopus 로고    scopus 로고
    • Declining genital warts in young women in England associated with HPV 16/18 vaccination: an ecological study
    • COI: 1:CAS:528:DC%2BC3sXhs1SisLvP, PID: 24092908
    • Howell-Jones R, Soldan K, Wetten S, et al. Declining genital warts in young women in England associated with HPV 16/18 vaccination: an ecological study. J Infect Dis. 2013;208(9):1397–403.
    • (2013) J Infect Dis , vol.208 , Issue.9 , pp. 1397-1403
    • Howell-Jones, R.1    Soldan, K.2    Wetten, S.3
  • 47
    • 84910639592 scopus 로고    scopus 로고
    • Why are anogenital warts diagnoses decreasing in the UK: bivalent human papillomavirus (HPV) vaccine cross-protection or failure to examine?
    • PID: 25398729
    • Clarke E, Board C, Patel N, Atkinson L, Tulloch H, Patel R. Why are anogenital warts diagnoses decreasing in the UK: bivalent human papillomavirus (HPV) vaccine cross-protection or failure to examine? Sex Transm Infect. 2014;90(8):587.
    • (2014) Sex Transm Infect , vol.90 , Issue.8 , pp. 587
    • Clarke, E.1    Board, C.2    Patel, N.3    Atkinson, L.4    Tulloch, H.5    Patel, R.6
  • 48
    • 84891957968 scopus 로고    scopus 로고
    • Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England
    • COI: 1:STN:280:DC%2BC2c7ks1GmsA%3D%3D, PID: 24211166
    • Mesher D, Soldan K, Howell-Jones R, et al. Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England. Vaccine. 2013;32(1):26–32.
    • (2013) Vaccine , vol.32 , Issue.1 , pp. 26-32
    • Mesher, D.1    Soldan, K.2    Howell-Jones, R.3
  • 49
    • 84901636857 scopus 로고    scopus 로고
    • Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
    • COI: 1:CAS:528:DC%2BC2cXmsFagu7c%3D, PID: 24736582
    • Kavanagh K, Pollock KG, Potts A, et al. Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types. Br J Cancer. 2014;110(11):2804–11.
    • (2014) Br J Cancer , vol.110 , Issue.11 , pp. 2804-2811
    • Kavanagh, K.1    Pollock, K.G.2    Potts, A.3
  • 50
    • 84885393164 scopus 로고    scopus 로고
    • Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation
    • COI: 1:CAS:528:DC%2BC3sXhs1SisLnM, PID: 24092907
    • Szarewski A, Skinner SR, Garland SM, et al. Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation. J Infect Dis. 2013;208(9):1391–6.
    • (2013) J Infect Dis , vol.208 , Issue.9 , pp. 1391-1396
    • Szarewski, A.1    Skinner, S.R.2    Garland, S.M.3
  • 51
    • 84880198301 scopus 로고    scopus 로고
    • Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010
    • COI: 1:CAS:528:DC%2BC3sXhtFSiu7zE, PID: 23785124
    • Markowitz LE, Hariri S, Lin C, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010. J Infect Dis. 2013;208(3):385–93.
    • (2013) J Infect Dis , vol.208 , Issue.3 , pp. 385-393
    • Markowitz, L.E.1    Hariri, S.2    Lin, C.3
  • 52
    • 84894331209 scopus 로고    scopus 로고
    • Human papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling
    • PID: 24552260
    • Delere Y, Remschmidt C, Leuschner J, et al. Human papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling. BMC Infect Dis. 2014;14(1):87.
    • (2014) BMC Infect Dis , vol.14 , Issue.1 , pp. 87
    • Delere, Y.1    Remschmidt, C.2    Leuschner, J.3
  • 53
    • 84930752776 scopus 로고    scopus 로고
    • Broeck DV
    • Depuydt C, Weyers S: Arbyn M. Early effects of human papillomavirus vaccination in Belgium. Eur J Cancer Prev
    • Merckx M, Broeck DV, Benoy I, Depuydt C, Weyers S, Arbyn M. Early effects of human papillomavirus vaccination in Belgium. Eur J Cancer Prev. 2014. doi:10.1097/cej.0000000000000067.
    • (2014) Benoy , vol.I
    • Merckx, M.1
  • 54
    • 84904569575 scopus 로고    scopus 로고
    • Early impact of human papillomavirus vaccination on cervical neoplasia–nationwide follow-up of young Danish women
    • Baldur-Felskov B, Dehlendorff C, Munk C, Kjaer SK. Early impact of human papillomavirus vaccination on cervical neoplasia–nationwide follow-up of young Danish women. J Natl Cancer Inst. 2014;25(7):915–22.
    • (2014) J Natl Cancer Inst , vol.25 , Issue.7 , pp. 915-922
    • Baldur-Felskov, B.1    Dehlendorff, C.2    Munk, C.3    Kjaer, S.K.4
  • 55
    • 84907303841 scopus 로고    scopus 로고
    • Cervical screening rates for women vaccinated against human papillomavirus
    • PID: 25163380
    • Budd AC, Brotherton JM, Gertig DM, Chau T, Drennan KT, Saville M. Cervical screening rates for women vaccinated against human papillomavirus. Med J Aust. 2014;201(5):279–82.
    • (2014) Med J Aust , vol.201 , Issue.5 , pp. 279-282
    • Budd, A.C.1    Brotherton, J.M.2    Gertig, D.M.3    Chau, T.4    Drennan, K.T.5    Saville, M.6
  • 56
    • 84896499760 scopus 로고    scopus 로고
    • Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia
    • PID: 24594809
    • Crowe E, Pandeya N, Brotherton JM, et al. Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia. BMJ. 2014;348:g1458.
    • (2014) BMJ , vol.348 , pp. 1458
    • Crowe, E.1    Pandeya, N.2    Brotherton, J.M.3
  • 57
    • 84886935298 scopus 로고    scopus 로고
    • Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
    • PID: 24148310
    • Gertig DM, Brotherton JM, Budd AC, Drennan K, Chappell G, Saville AM. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study. BMC Med. 2013;11:227.
    • (2013) BMC Med , vol.11 , pp. 227
    • Gertig, D.M.1    Brotherton, J.M.2    Budd, A.C.3    Drennan, K.4    Chappell, G.5    Saville, A.M.6
  • 58
    • 84888061679 scopus 로고    scopus 로고
    • Population impact of HPV vaccines: summary of early evidence
    • PID: 24263069
    • Hariri S, Markowitz LE, Dunne EF, Unger ER. Population impact of HPV vaccines: summary of early evidence. J Adolesc Health 2013;53(6):679–82.
    • (2013) J Adolesc Health , vol.53 , Issue.6 , pp. 679-682
    • Hariri, S.1    Markowitz, L.E.2    Dunne, E.F.3    Unger, E.R.4
  • 59
    • 84904640110 scopus 로고    scopus 로고
    • Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil(R)): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts
    • COI: 1:CAS:528:DC%2BC2cXhtFCqu7bE, PID: 25022951
    • McCormack PL. Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil(R)): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts. Drugs 2014;74(11):1253–83.
    • (2014) Drugs , vol.74 , Issue.11 , pp. 1253-1283
    • McCormack, P.L.1
  • 60
    • 84925473522 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDSS):. Accessed Feb 28, 2014
    • Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDSS): http://wwwn.cdc.gov/nndss/. Accessed Feb 28, 2014.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.